Investigating bifidobacteria and human milk oligosaccharide composition of lactating mothers.


Journal

FEMS microbiology ecology
ISSN: 1574-6941
Titre abrégé: FEMS Microbiol Ecol
Pays: England
ID NLM: 8901229

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 27 11 2019
accepted: 17 03 2020
pubmed: 20 3 2020
medline: 31 5 2022
entrez: 20 3 2020
Statut: ppublish

Résumé

Human milk is known to carry its own microbiota, of which the precise origin remains obscure. Breastfeeding allows mother-to-baby transmission of microorganisms as well as the transfer of many other milk components, such as human milk oligosaccharides (HMOs), which act as metabolizable substrates for particular bacteria, such as bifidobacteria, residing in infant intestinal tract. In the current study, we report the HMO composition of 249 human milk samples, in 163 of which we quantified the abundance of members of the Bifidobacterium genus using a combination of metagenomic and flow cytometric approaches. Metagenomic data allowed us to identify four clusters dominated by Bifidobacterium adolescentis and Bifidobacterium pseudolongum, Bifidobacterium crudilactis or Bifidobacterium dentium, as well as a cluster represented by a heterogeneous mix of bifidobacterial species such as Bifidobacterium breve and Bifidobacterium longum. Furthermore, in vitro growth assays on HMOs coupled with in silico glycobiome analyses allowed us to elucidate that members of the Bifidobacterium bifidum and B. breve species exhibit the greatest ability to degrade and grow on HMOs. Altogether, these findings indicate that the bifidobacterial component of the human milk microbiota is not strictly correlated with their ability to metabolize HMOs.

Identifiants

pubmed: 32188978
pii: 5809960
doi: 10.1093/femsec/fiaa049
pii:
doi:

Substances chimiques

Oligosaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© FEMS 2020.

Auteurs

Gabriele Andrea Lugli (GA)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.

Sabrina Duranti (S)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.

Christian Milani (C)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.

Leonardo Mancabelli (L)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.

Francesca Turroni (F)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
Microbiome Research Hub, University of Parma, Parma, Italy.

Giulia Alessandri (G)

Department of Veterinary Medical Science, University of Parma, Parma, Italy.

Giulia Longhi (G)

GenProbio srl, Parma, Italy.

Rosaria Anzalone (R)

GenProbio srl, Parma, Italy.

Alice Viappinai (A)

GenProbio srl, Parma, Italy.

Chiara Tarracchini (C)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.

Sergio Bernasconi (S)

Microbiome Research Hub, University of Parma, Parma, Italy.

Chloe Yonemitsu (C)

Department of Pediatrics and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence, University of California-San Diego, La Jolla, CA, USA.

Lars Bode (L)

Department of Pediatrics and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence, University of California-San Diego, La Jolla, CA, USA.

Michael I Goran (MI)

Department of Pediatrics, Children's Hospital Los Angeles, The University of Southern California, Los Angeles, CA, USA.

Maria Cristina Ossiprandi (MC)

Department of Veterinary Medical Science, University of Parma, Parma, Italy.

Douwe van Sinderen (D)

APC Microbiome Institute and School of Microbiology, Bioscience Institute, National University of Ireland, Cork, Ireland.

Marco Ventura (M)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
Microbiome Research Hub, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH